Literature DB >> 6813005

Detection of polymeric IgA in glomeruli from patients with IgA nephropathy.

Y Tomino, H Sakai, M Miura, M Endoh, Y Nomoto.   

Abstract

A study on the detection of polymeric IgA in glomeruli from renal biopsy specimens in patients with IgA nephropathy is described. Renal biopsy specimens were obtained from patients with IgA nephropathy. These specimens were stained with FITC-labelled anti-human J chain antisera and then examined with a fluorescent microscope. The J chain was observed in the glomerular mesangium by immunofluorescent staining. In parallel studies, renal biopsy specimens were treated with citrate buffer (pH 3.2) and the 'eluate' was neutralized by sodium hydroxide. The eluate was labelled with iodine-125, and the radiolabelled 'eluate' was fractionated by sucrose density-gradient ultracentrifugation. Polymerized IgA in the 'eluate' obtained from patients with IgA nephropathy was found to sediment predominantly as 9S to 11S using a sucrose density gradient analysis. Polymeric IgA in the fractions of the density gradient analysis was determined by anti-human IgA and anti-human J chain antisera. It was demonstrated that IgA and J chain were eluted from the glomeruli in some patients with IgA nephropathy. It is concluded that IgA deposited in the glomeruli is composed of dimers and/or larger polymers of circulating IgA in some patients with IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813005      PMCID: PMC1536483     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Recurrence of mesangial deposition of IgA after renal transplantation.

Authors:  J Berger; H Yaneva; B Nabarra; C Barbanel
Journal:  Kidney Int       Date:  1975-04       Impact factor: 10.612

2.  Ultrastructural localization of J chain in human intestinal mucosa.

Authors:  H Nagura; P Brandtzaeg; P K Nakane; W R Brown
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

Review 3.  IgA-Associated glomerulonepbritis.

Authors:  D C Lowance; J D Mullins; J J McPhaul
Journal:  Int Rev Exp Pathol       Date:  1977

4.  IgA nephropathy.

Authors:  R C McCoy; C R Abramowsky; C C Tisher
Journal:  Am J Pathol       Date:  1974-07       Impact factor: 4.307

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  IgA glomerular deposits in renal disease.

Authors:  J Berger
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

7.  Studies on J chain and binding site for secretory component in circulating human B cells. II. The cytoplasm.

Authors:  P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

8.  Identification of J-chain in polymeric immunoglobulins from a variety of species by cross-reaction with rabbit antisera to human J-chain.

Authors:  K Kobayashi; J P Vaerman; H Bazin; A M LeBacq-Verheyden; J F Heremans
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

9.  IgA nephropathy: clinicopathology and immunopathology.

Authors:  T Shirai; Y Tomino; M Sato; T Yoshiki; T Itoh
Journal:  Contrib Nephrol       Date:  1978       Impact factor: 1.580

10.  Controlled trial of phenytoin therapy in IgA nephropathy.

Authors:  A R Clarkson; A E Seymour; A J Woodroffe; P E McKenzie; Y L Chan; A M Wootton
Journal:  Clin Nephrol       Date:  1980-05       Impact factor: 0.975

View more
  40 in total

1.  Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.

Authors:  L-L Liu; Y Jiang; L-N Wang; N Liu
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  Development of Animal Models of Human IgA Nephropathy.

Authors:  Hitoshi Suzuki; Yusuke Suzuki; Jan Novak; Yasuhiko Tomino
Journal:  Drug Discov Today Dis Models       Date:  2014

3.  Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.

Authors:  L Layward; A C Allen; S J Harper; J M Hattersley; J Feehally
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

4.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

5.  The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response.

Authors:  R C Bartholomeusz; B D Forrest; J T Labrooy; P L Ey; D Pyle; D J Shearman; D Rowley
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

6.  Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors:  Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2012-08-05       Impact factor: 4.307

7.  Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA.

Authors:  S J Harper; A C Allen; J H Pringle; J Feehally
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

8.  Immune response to oral polio vaccine in patients with IgA glomerulonephritis.

Authors:  P O Leinikki; J Mustonen; A Pasternack
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

9.  Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA.

Authors:  A Rifai; K Millard
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

10.  Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1.

Authors:  Koshi Yamada; Noriyoshi Kobayashi; Tomomi Ikeda; Yusuke Suzuki; Toshinao Tsuge; Satoshi Horikoshi; Steven N Emancipator; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2010-06-15       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.